Effectiveness and cost of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in obesity services (STRIVE study): study protocol of an open-label, real-world, randomised, controlled trial.
- DOI
- 10.1136/bmjopen-2019-034137
- Published
- 2020 Feb 13
- Container
- BMJ open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bmjopen-2019-034137,
title = {Effectiveness and cost of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in obesity services (STRIVE study): study protocol of an open-label, real-world, randomised, controlled trial.},
author = {Papamargaritis D and Al-Najim W and Lim J and Crane J and Lean M and le Roux C and McGowan B and O'Shea D and Webb D and Wilding J and Davies MJ},
year = {2020},
journal = {BMJ open},
doi = {10.1136/bmjopen-2019-034137},
url = {https://doi.org/10.1136/bmjopen-2019-034137}
}RIS
TY - JOUR TI - Effectiveness and cost of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in obesity services (STRIVE study): study protocol of an open-label, real-world, randomised, controlled trial. AU - Papamargaritis D AU - Al-Najim W AU - Lim J AU - Crane J AU - Lean M AU - le Roux C AU - McGowan B AU - O'Shea D AU - Webb D AU - Wilding J AU - Davies MJ PY - 2020 JO - BMJ open DO - 10.1136/bmjopen-2019-034137 UR - https://doi.org/10.1136/bmjopen-2019-034137 ER -
APA
D, P., W, A., J, L., J, C., M, L., C, L. R., B, M., D, O., D, W., J, W., & MJ, D. (2020). Effectiveness and cost of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in obesity services (STRIVE study): study protocol of an open-label, real-world, randomised, controlled trial.. BMJ open. https://doi.org/10.1136/bmjopen-2019-034137
Source records
- pubmed · retrieved 2026-09-27T01:08:22.603Z